BCL2 and diffuse large B-cell lymphoma: Double-expressor lymphoma is DLBCL with Co-expression of c-MYC and BCL2 proteins by immunohistochemistry, and accounts for 21 to 34% of newly diagnosed DLBCL patients (5).